STING1 and melanoma: Indeed, we previously reported that activation of STING signaling in human melanoma cell lines can increase their antigenicity by upregulating MHC class I molecules, leading to more effective immune recognition and antigen presentation to tumor-infiltrating lymphocytes (TIL)29.